Startups channel feed – Endpoints News

Startups channel feed

Yale spinout re-engineers an immunotherapy GSK, others once abandoned

5 years ago

A virtual biotech incubator is launching with the help of Evotec and Samsara, looking for a few good scientists in need of seed cash for spinouts

5 years ago

Better than Eylea, as durable as gene therapy? Perceptive, Xontogeny boost ophthalmic startup's shot for best of all worlds

5 years ago

Nan Fung Life Sciences antes up $32M to fuel a neuro play as the Hong Kong conglomerate burns through $1.5B mandate

5 years ago

All in on IL-11, Frazier unveils latest startup with dual focus on fibrosis and cancer

5 years ago

A Bay Area upstart with legendary godfathers breaks cover, touting claims of a curative tech, unicorn status and a $300M plan to shoot for an approval

5 years ago

Shattuck Labs ends silence with a shout-out on $118M raise for fusion protein work

5 years ago

Going where PROTACs can't, Versant unveils $50M bet on Carolyn Bertozzi's LYTAC tech — with a rising star at the helm

5 years ago

ARCH-backed Autobahn launches with $76M to rebuild myelin and reverse MS

5 years ago

Add ear gene therapy company Akouos to the ever-growing list of IPOs amid Covid-19

5 years ago

IPOs abound in the time of coronavirus, as Forma Therapeutics pencils in $150M Nasdaq debut

5 years ago

Versant-backed, Bristol Myers-stamped Repare Therapeutics guns for $100M IPO

5 years ago

For a post-Soliris world, Atlas-backed Q32 Bio outlines $46M next-gen complement play

5 years ago

Daphne Koller’s AI startup gets $143M in new cash from a16z, others

5 years ago

Bezos, Paul Allen funds, a16z put up $100M to build an Illumina of human proteins

5 years ago

BARDA offers a tiny startup up to $812M to create a US-based drug manufacturer — and the CEO comes with a price gouging controversy on his résumé

5 years ago

Martin Mackay’s rare disease startup gets $145 million as it enters the clinic

5 years ago

Precision therapy approach secures small biotech $42M haul to combat disease that inspired the Ice Bucket Challenge

5 years ago

Vivek Ramaswamy’s brother, Shankar, spins out on his own, launching audacious gene therapy play

5 years ago

Spun out of George Church's lab, this biotech upstart is mapping the AAV universe for Novartis, Sarepta to gaze

5 years ago

Blood test for cancer detection company Grail rakes in $390M in latest round

6 years ago

'It's pure art': Versant, GV reveal $60M bet that a clearer look at inflammasomes can lead to better drugs

6 years ago

Praxis Precision Medicines launches with $100M and bold sights on long-evasive neurological disorders

6 years ago

The biopharma funding engine motors on, as Chinese biotech raises nearly $280M in monster round

6 years ago

First page Previous page 51 52 535455 56 57 Next page Last page